Your browser doesn't support javascript.
loading
Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF-ß1-Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis.
Kuang, Xiaolan; Ma, Ting; Cai, Wanna; Yang, Jianzhan; Sun, Biao; Zhang, Xiaoqi; Liu, Bo; Wang, Sumei; Xu, Fangfang.
Afiliación
  • Kuang X; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Ma T; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Cai W; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Yang J; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Sun B; Guangdong Provincial Engineering Research Center for Modernization of TCM, NMPA Key Laboratory for Quality Evaluation of TCM, Jinan University, Guangzhou, 510632, P. R. China.
  • Zhang X; Guangdong Provincial Engineering Research Center for Modernization of TCM, NMPA Key Laboratory for Quality Evaluation of TCM, Jinan University, Guangzhou, 510632, P. R. China.
  • Liu B; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Wang S; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
  • Xu F; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, <510006>,
Chem Biodivers ; 20(3): e202201110, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36825591
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Medicamentos Herbarios Chinos / Rhamnaceae Tipo de estudio: Prognostic_studies Idioma: En Revista: Chem Biodivers Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Medicamentos Herbarios Chinos / Rhamnaceae Tipo de estudio: Prognostic_studies Idioma: En Revista: Chem Biodivers Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2023 Tipo del documento: Article